OBLN

Obalon Therapeutics, Inc. (OBLN) | Rumor.io

Obalon Therapeutics

OBLN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about OBLN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Oct 16

Obalon Therapeutics, Inc. (OBLN) has been acquired, according to a recent find.
The acquisition of OBLN is a new development in the market.
The ticker OBLN has been associated with a position held by Armistice Capital.

Generated by AI

Sentiment

Of the messages about OBLN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Bullish· Jun 17

$OBLN has a strong growth in EPS, with a 69.53% increase.
The company's low float, with a volume of 5k and a move of 20%, indicates significant potential for price appreciation.
The merger has increased the company's market cap, making it a prime target for investors, with a potential correction and subsequent price increase expected.

Bearish· Jun 17

The merger between Obalon Therapeutics and another company has been a disaster, resulting in a significant loss in value.
The low float of the stock makes it more susceptible to rapid price drops, and some investors believe it's better to short the stock rather than hold it.
The company's management is under fire, with some calling for their resignation due to the poor handling of the merger and the subsequent stock performance.

Generated by AI

Topics

Of the messages about OBLN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· May 10

Obalon Therapeutics, Inc. announced earnings with an EPS of $0.71, missing estimates.
The earnings announcement was made for the company's Obalon Therapeutics, Inc. stock, ticker $OBLN.
The earnings report showed a miss in estimates for the company's Obalon Therapeutics, Inc. stock.

Announcements· Jun 15

Obalon Therapeutics, Inc. ($OBLN) is set to merge with ReShape Lifesciences Inc. ($RSLS) and will be renamed "ReShape Lifesciences Inc." after the merger.
The merged company's stock is expected to begin trading on the Nasdaq Capital Market under the symbol "RSLS" on Wednesday.
Obalon Therapeutics will undergo a 1-for-3 reverse stock split after the merger, and the company's common stock will be renamed "ReShape Lifesciences Inc."

Technical Analysis· May 25

The Obalon Therapeutics, Inc. ($OBLN) chart is showing a bull flag forming, indicating a potential upward movement.
The stock has been trading below its 100 moving average, which could be a sign of a reversal, with a strong support level at $3.43.
The daily chart shows price action notably above the top band of the Bollinger Bands, indicating a bullish trend, but the stock is also showing signs of a potential downtrend, with a possible drop to $3.40.

Generated by AI

Community

Of the messages about OBLN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	—
Newcomers	—	—	—	—

Regulars· Jun 15

$OBLN is expected to rally over $4 after a long sub at $3.50, with potential targets at $4.88 and $5.85.
The merger between $OBLN and ReShape LifeSciences has been halted, with the latter expected to make a triumphant return to the market, possibly with a new name.
$OBLN's stock split is expected to be 1-for-3, with the company to be renamed "ReShape Lifesciences Inc." after the merger.

Newcomers· Jun 16

New users are excited about the potential for a squeeze in OBLN shares due to the low float, expecting prices to rise significantly.
The merger of OBLN and RSLS has caused technical issues for some users, with Charles Schwab users unable to see their OBLN shares under the new RSLS ticker, and others experiencing delays in transactions.
Some users are speculating about the exact ratio of OBLN shares to RSLS shares, with one user reporting that they were told by a broker that 1 share of RSLS corresponds to every 3 shares of OBLN.

Generated by AI

Also Discussed

Investors talking about OBLN also mention

#	Name	Attention
1	Eltek Ltd.ELTK	0%new
2	Legacy Education Inc.LGCY	0%new
3	Outlook Therapeutics Inc.OTLK	0.01%-0.01
4	Precipio Inc.PRPO	0%0
5	Viveve Medical Inc.VIVE	0%0
6	Protara Therapeutics, Inc.TARA	0%0
7	NovaBay Pharmaceuticals, Inc.NBY	0%0
8	Bio-Path Holdings Inc.BPTH	0%0
9	Bridgeline Digital IncBLIN	0%new
10	Alpha Metallurgical Resources, Inc.AMR	0%0